Published in

Wiley, Journal of Bone and Mineral Research, 1(28), p. 162-168, 2012

DOI: 10.1002/jbmr.1731

Links

Tools

Export citation

Search in Google Scholar

Microindentation for In Vivo Measurement of Bone Tissue Material Properties in Atypical Femoral Fracture Patients and Controls

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Atypical femoral fractures (AFF) associated with long-term bisphosphonates (LTB) are a growing concern. Their aetiology is unknown but bone material properties might be deteriorated. In an AFF series, we analyzed the bone material properties by microindentation. Four groups of patients were included: 6 AFF, 38 typical osteoporotic fractures, 6 LTB and 20 controls without fracture. Neither typical osteoporotic fractures nor controls have received any antiosteoporotic medication. A general laboratory workup, bone densitometry by DXA and microindentation testing at the tibia was done in all patients. Total indentation distance (Total ID), Indentation distance increase (IDI) and Creep indentation distance (Creep ID) were measured (microns). Age-adjusted ANCOVA analysis was used for comparisons. Controls were significantly younger than fracture groups. Bisphosphonate exposure was on average 5.5 years (range 5-12) for the AFF and 5.4 years (range 5-8) for the LTB groups. Total ID (microns) showed better material properties (lower Total ID) for controls 36 (±6) (mean±SD) than for AFF 46(±4) and for typical femoral fractures 47 (±13) respectively. Patients on LTB showed values between controls and fractures, 38(±4), although not significantly different from any of the other three groups. IDI values showed a similar pattern 13 (±2), 16 (±6), 19 (±3) and 18 (±5). After adjusting by age, significant differences were seen between controls, typical (P<0.001) and atypical fractures (P=0.03) for Total ID and for IDI (P<0.001 and P<0.05 respectively). There were no differences in Creep ID between groups. Our data suggest that patients with AFF have a deep deterioration in bone material properties at a tissue level similar to that for the osteoporotic fracture group. The LTB group shows levels that are in between controls and both type of fractures although not statistically different. These results suggest that bisphosphonate therapy probably does not put the majority of patients at risk for AFF. © 2012 American Society for Bone and Mineral Research.